Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein

References

• Douketis JD, Gu CS, Schulman S, et al. The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism. Ann Intern Med. 2007;147:766–774.
   PubMed Web of Science ®Google Scholar
• Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756–764.
   PubMed Web of Science ®Google Scholar
• Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44:62–69.
   PubMed Web of Science ®Google Scholar
• Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost. 2005;3:1611–1617.
   PubMed Web of Science ®Google Scholar
• Lippi G, Favaloro EJ, Montagnana M, et al. C-reactive protein and venous thromboembolism: causal or casual association? Clin Chem Lab Med. 2010;48:1693–1701.
   PubMed Web of Science ®Google Scholar
• Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005;94:362–365.
   PubMed Web of Science ®Google Scholar
• Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12:464–474.
   PubMed Web of Science ®Google Scholar
• Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985;28:429–439.
   PubMed Web of Science ®Google Scholar
• Velasquez Forero F, Garcia Prugue N, Ruiz Morales N. Idiopathic nephrotic syndrome of the adult with asymptomatic thrombosis of the renal vein. Am J Nephrol. 1988;8:457–462.
   PubMed Web of Science ®Google Scholar
• Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006;118:397–407.
   PubMed Web of Science ®Google Scholar
• Mahmoodi BK, Gansevoort RT, Veeger NJ, et al. Microalbuminuria and risk of venous thromboembolism. JAMA. 2009;301:1790–1797.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Wood C, Wagner I, et al. Idiopathic membranous nephropathy in an Australian population: the incidence of thromboembolism and its impact on the natural history. Nephron. 1993;63:240–241.
   PubMed Web of Science ®Google Scholar
• Gyamlani G, Molnar MZ, Lu JL, et al. Association of serum albumin level and venous thromboembolic events in a large cohort of patients with nephrotic syndrome. Nephrol Dial Transplant. 2017;32:157–164.
   PubMed Web of Science ®Google Scholar
• Konigsbrugge O, Posch F, Riedl J, et al. Association between decreased serum albumin with risk of venous thromboembolism and mortality in cancer patients. Oncologist. 2016;21:252–257.
   PubMed Web of Science ®Google Scholar
• Mahmoodi BK, ten Kate MK, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation. 2008;117:224–230.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Lutsey PL, Heckbert SR, et al. Serum albumin and risk of venous thromboembolism. Thromb Haemost. 2010;104:100–104.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Sameul S, Blom AW, et al. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence. Eur J Epidemiol. 2017;32:657–667.
   PubMed Web of Science ®Google Scholar
• Salonen JT. Is there a continuing need for longitudinal epidemiologic research? The Kuopio ischaemic heart disease risk factor study. Ann Clin Res. 1988;20:46–50.
   PubMedGoogle Scholar
• Kunutsor SK, Laukkanen JA. Serum zinc concentrations and incident hypertension: new findings from a population-based cohort study. J Hypertens. 2016;34:1055–1061.
   PubMed Web of Science ®Google Scholar
• Everson SA, Kaplan GA, Goldberg DE, et al. Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Hypertension. 1996;27:1059–1064.
   PubMed Web of Science ®Google Scholar
• Salonen JT, Nyyssonen K, Korpela H, et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803–811.
   PubMed Web of Science ®Google Scholar
• Laukkanen JA, Laaksonen D, Lakka TA, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol. 2009;103:1598–1604.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Khan H, Laukkanen JA. Serum albumin concentration and incident type 2 diabetes risk: new findings from a population-based cohort study. Diabetologia. 2015;58:961–967.
   PubMed Web of Science ®Google Scholar
• Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York (NY): Springer; 2000.
   Google Scholar
• Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stat Med. 1991;10:1025–1035.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Kurl S, Zaccardi F, et al. Baseline and long-term fibrinogen levels and risk of sudden cardiac death: a new prospective study and meta-analysis. Atherosclerosis. 2016;245:171–180.
   PubMed Web of Science ®Google Scholar
• Kunutsor SK, Laukkanen JA, Bluemke DA, et al. Baseline and long-term gamma-glutamyltransferase, heart failure and cardiac arrhythmias in middle-aged Finnish men: prospective study and pooled analysis of published evidence. Eur J Prev Cardiolog. 2016;23:1354–1362.
   PubMed Web of Science ®Google Scholar
• Groenwold RH, Klungel OH, Grobbee DE, et al. Selection of confounding variables should not be based on observed associations with exposure. Eur J Epidemiol. 2011;26:589–593.
   PubMed Web of Science ®Google Scholar
• Das I. Raised C-reactive protein levels in serum from smokers. Clin Chim Acta. 1985;153:9–13.
   PubMed Web of Science ®Google Scholar
• Shaper AG, Wannamethee SG, Whincup PH. Serum albumin and risk of stroke, coronary heart disease, and mortality: the role of cigarette smoking. J Clin Epidemiol. 2004;57:195–202.
   PubMed Web of Science ®Google Scholar
• Olson NC, Cushman M, Lutsey PL, et al. Inflammation markers and incident venous thromboembolism: the Reasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. J Thromb Haemost. 2014;12:1993–2001.
   PubMed Web of Science ®Google Scholar
• Reitsma PH, Rosendaal FR. Activation of innate immunity in patients with venous thrombosis: the Leiden thrombophilia study. J Thromb Haemost. 2004;2:619–622.
   PubMed Web of Science ®Google Scholar
• van Aken BE, Reitsma PH, Rosendaal FR. Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol. 2002;116:173–177.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Lutsey PL, Astor BC, et al. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort. Thromb Haemost. 2009;102:615–619.
   PubMed Web of Science ®Google Scholar
• Danesh J, Muir J, Wong YK, et al. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J. 1999;20:954–959.
   PubMed Web of Science ®Google Scholar
• Sogaard KK, Horvath-Puho E, Gronbaek H, et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol. 2009;104:96–101.
   PubMed Web of Science ®Google Scholar
• Prandoni P, Bilora F, Marchiori A, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med. 2003;348:1435–1441.
   PubMed Web of Science ®Google Scholar
• Crous-Bou M, Harrington LB, Kabrhel C. Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost. 2016;42(8):808–820.
   Web of Science ®Google Scholar
• Gustafsson JE. Improved specificity of serum albumin determination and estimation of “acute phase reactants by use of the bromcresol green reaction” . Clin Chem. 1976;22:616–622.
   PubMed Web of Science ®Google Scholar
• Smabrekke B, Rinde LB, Hindberg K, et al. Atherosclerotic risk factors and risk of myocardial infarction and venous thromboembolism; Time-fixed versus time-varying analyses. The Tromso study. PLoS One. 2016;11:e0163242.
   PubMedGoogle Scholar
• Horvei LD, Grimnes G, Hindberg K, et al. C-reactive protein, obesity, and the risk of arterial and venous thrombosis. J Thromb Haemost. 2016;14:1561–1571.
   PubMed Web of Science ®Google Scholar
• Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998;279:1477–1482.
   PubMed Web of Science ®Google Scholar